KETAMINE FOR PTSD

Ketamine targets AMPA/NMDA receptors that are critically involved in mood regulation and memory processing. For individuals with PTSD, traumatic memories become locked in rigid neural circuits that repeatedly trigger the fight-or-flight response. Ketamine helps disrupt these maladaptive patterns.

By promoting rapid synaptogenesis — the formation of new neural connections — ketamine allows the brain to process traumatic memories in a new context. This neuroplasticity enables patients to reframe their relationship with traumatic experiences, reducing the emotional charge associated with intrusive memories and flashbacks.

Research demonstrates that ketamine's effect on the glutamate system can produce rapid and meaningful symptom relief, sometimes within hours of the first infusion. This is particularly significant for PTSD patients who often struggle with conventional treatments that may take weeks or months to show benefit.

Research shows that ketamine provides rapid symptom improvement within hours of treatment for many PTSD patients. Multiple clinical studies have demonstrated that IV ketamine can significantly reduce PTSD symptom severity, with effects observable within 24 hours of the first infusion.

For veterans and trauma survivors who have not found adequate relief through conventional approaches such as prolonged exposure therapy or SSRIs alone, ketamine represents a promising adjunctive treatment that can accelerate the healing process and provide the neurological foundation for deeper therapeutic work.